LEADER 01177nam 2200301z- 450 001 9910689839903321 005 20161209104720.0 035 $a(CKB)5860000000036385 035 $a(BIP)012364157 035 $a(EXLCZ)995860000000036385 100 $a20220406c2004uuuu -u- - 101 0 $aeng 200 10$aWhat's the hold up? $ea review of security clearance backlog and reciprocity issues plaguing today's government and private sector workforce : hearing before the Committee on Government Reform, House of Representatives, One Hundred Eighth Congress, second session, May 6, 2004 215 $a1 online resource (iii, 176 p.) $cill 311 $a0-16-074084-3 517 $aWhat's the hold up? 606 $aSecurity clearances$zUnited States 606 $aDefense industries$zUnited States$xPersonnel management 606 $aEmployee screening$zUnited States 610 $aDefense industries 610 $aTechnology & engineering 615 0$aSecurity clearances 615 0$aDefense industries$xPersonnel management. 615 0$aEmployee screening 906 $aBOOK 912 $a9910689839903321 996 $aWhat's the hold up$93112901 997 $aUNINA LEADER 04473nam 22005655 450 001 9910766884403321 005 20260119124130.0 010 $a3-031-45586-X 024 7 $a10.1007/978-3-031-45586-5 035 $a(MiAaPQ)EBC30975878 035 $a(Au-PeEL)EBL30975878 035 $a(DE-He213)978-3-031-45586-5 035 $a(CKB)29089603800041 035 $a(EXLCZ)9929089603800041 100 $a20231127d2023 u| 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aCOVID-19 in Dermatology /$fedited by Hazel H. Oon, Chee Leok Goh 205 $a1st ed. 2023. 210 1$aCham :$cSpringer Nature Switzerland :$cImprint: Springer,$d2023. 215 $a1 online resource (189 pages) 225 1 $aUpdates in Clinical Dermatology,$x2523-8892 311 08$aPrint version: Oon, Hazel H. COVID-19 in Dermatology Cham : Springer,c2024 327 $aChapter 1. The Science of COVID-19 Disease -- Chapter 2. Cutaneous Manifestations of COVID-19 -- Chapter 3. Cutaneous Reactions to COVID-19 mRNA Vaccines -- Chapter 4. Cutaneous Reactions to non mRNA COVID-19 vaccines -- Chapter 5. Evaluation of the Patient With a Coronavirus Disease (COVID-19) Vaccine Cutaneous Reaction -- Chapter 6. Personal Protective Equipment (PPE) related Occupational Dermatoses during COVID 19 -- Chapter 7. COVID-19 OUTBREAK RESPONSE IN DERMATOLOGY -- Chapter 8. Leveraging on teledermatology in the COVID-19 pandemic -- Chapter 9. COVID-19 Dermatology Registries and the Impact of COVID-19 on Dermatology Research -- Chapter 10. Impact of COVID-19 on dermatology medical education -- Chapter 11. Management of immunosuppressed dermatology patients during COVID-19 -- Chapter 12. Therapeutic considerations of COVID-19 on aesthetic dermatology, dermatosurgery and skin cancer -- Chapter 13. Psychological aspects, sychodermatology and vaccine hesitancy during the COVID-19 pandemic -- Chapter 14. Oral COVID-19 Antiviral Agents in Dermatology Outpatient Treatment -- Chapter 15. The Economic Impact of COVID-19 on Dermatology . 330 $aSince the first cases of an acute respiratory illness were reported, the pathogen SARS-coV-2 (severe acute respiratory syndrome coronavirus 2) and its disease, COVID-19 have disrupted the world and changed the course of medical history. Clinics were under lockdown and supplies of critical drugs such as biologics and meladinine were delayed. The prolonged impact of disease has taken its toll on patients, their careers, medical staff, research and medical education. Shortly after the first landmark studies of COVID-19 vaccine trial data were made known, global mass vaccination programs were underway. Vaccine technology has expanded beyond messenger RNA (mRNA) to include non-replicating viral vectors, inactivated virus, and protein subunits. Cutaneous manifestations of vaccine reactions, including non-mRNA and their morphological patterns, indications and contraindications, vaccine global access, equity, allocation of booster doses, emerging COVID variants and subvariants, waning vaccine and treatment efficacy are the issues that begged to be explored. New oral therapies are available for treatment of COVID-19 but they bring with them drug-drug interactions and potential side effects. This book is a compilation of a concerted effort by dermatologists across the globe to join hands against COVID-19. Each chapter has been written by experts in the field, with first-hand experience and synthesized literature to offer the most up-to-date coverage in the fast-paced, changing landscape of COVID-19 in dermatology. COVID-19 in Dermatology is a valuable resource for dermatologists, dermatology residents and medical students, and general practitioners. . 410 0$aUpdates in Clinical Dermatology,$x2523-8892 606 $aDermatology 606 $aDermatology 606 $aCOVID-19$2thub 606 $aVacunes$2thub 606 $aDermatologia$2thub 608 $aLlibres electrònics$2thub 615 0$aDermatology. 615 14$aDermatology. 615 7$aCOVID-19 615 7$aVacunes 615 7$aDermatologia 676 $a616.5 700 $aOon$b Hazel H$01450635 701 $aGoh$b Chee Leok$01133652 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910766884403321 996 $aCOVID-19 in Dermatology$93650114 997 $aUNINA